Patent · US Active

Anti-Pre-S1 HBV antibodies

US10544205B2 · kind B2 · utility

1Cited by

2References

8Claims

0Family size

Assignee

HUAHUI HEALTH LTD. · CN

Inventors

Jianhua Sui · Waltham, US
Dan Li · Shoreview, US
Wenhui Li · Nanhu, CN

Key dates

Filing date	Jan 8, 2018
Grant date	Jan 28, 2020
Priority date	—
Expiry date	Jan 8, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are human antibodies that specifically bind to HBV Pre-S1 domain ligand and inhibit HBV or HDV infection, antibodies binding to a set of amino acid residues that are critical for viral receptor engagement, and uses of these antibodies to prevent, or treat or diagnose HBV or HDV infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.